Evidence map›Paper›PMID 37887764›Full record

ArticlePathogens (Basel, Switzerland)2023

Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case-Control Diagnostic Validation Study.

Kris Hage, Marita van de Kerkhof, Anders Boyd, Joanne M Carson, Astrid M Newsum, Amy Matser, Marc van der Valk, Kees Brinkman, Joop E Arends, Fanny N Lauw and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Kris HageDepartment of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, The Netherlands.ORCID 0000-0002-3273-3933
Marita van de KerkhofDepartment of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, The Netherlands.
Anders BoydDepartment of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, The Netherlands.
Joanne M CarsonThe Kirby Institute, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0001-8043-0200
Astrid M NewsumDepartment of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, The Netherlands.
Amy MatserDepartment of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, The Netherlands.
Marc van der ValkInfectious Diseases, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands.
Kees BrinkmanDepartment of Internal Medicine, Onze Lieve Vrouwe Gasthuis (OLVG), 1091 AC Amsterdam, The Netherlands.
Joop E ArendsDepartment of Internal Medicine and Infectious Diseases, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.
Fanny N LauwDepartment of Internal Medicine, Medical Centre Jan van Goyen, 1075 HN Amsterdam, The Netherlands.
Bart J A RijndersDepartment of Internal Medicine and Infectious Diseases, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Arne van EedenDepartment of Internal Medicine, DC Klinieken Oud Zuid, 1075 BG Amsterdam, The Netherlands.
Marianne MartinelloThe Kirby Institute, University of New South Wales, Sydney 2052, Australia.
Gail V MatthewsThe Kirby Institute, University of New South Wales, Sydney 2052, Australia.
Janke SchinkelMedical Microbiology and Infection Prevention, Amsterdam UMC Location, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Maria PrinsDepartment of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, The Netherlands.
GGD Amsterdam · NLUNSW Sydney · AUStichting HIV Monitoring · NLAmsterdam University Medical Centers · NLErasmus MC · NLOLVG · NLUniversity Medical Center Utrecht · NL

Funding

Aidsfonds 2008.026, 2013.037Netherlands Organisation for Health Research and Development 522004006
6 · The paper itself

Abstract

We assessed the predictive capacity of the HCV-MOSAIC risk score, originally developed for primary early HCV infection, as a screening tool for HCV reinfection in 103 men who have sex with men (MSM) with HIV using data from the MOSAIC cohort, including MSM with HIV/HCV-coinfection who became reinfected (cases,

Indexed as

HCVHCV reinfectionHIV/hepatitis C virus coinfectionMSMrisk behaviour

Identifiers

PMID37887764
PMCPMC10610046
OpenAlexW4387673722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.